CDKN2A and neoplasm: Although the tumour‐suppressor p16INK4A is a well‐documented target of BMI1‐induced gene silencing,9, 11 knockdown of BMI1 did not significantly change p16INK4A expression either in mRNA or protein level in our study (Figure S4B,C).